Cardiology

Myeloma

Questions discussed in this category

In a patient with cardiac light chain amyloid who has significant heart failure symptoms, including inotrope dependence at presentation, how much clinical benefit does treatment provide?

How long would you treat before considering palliative care alone?

1 Answer available

Are there situations where you would start treatment for cardiac amyloid in a patient with amyloid seen on biopsy, but still pending mass spectrometry results?

E.g. in a patient with tenuous cardiac function, would starting treatment several weeks earlier potentially improve outcomes?

1 Answer available

Papers discussed in this category

American journal of hematology, 2023 Dec 15

Reduced early mortality with Daratumumab-based frontline therapy in AL amyloidosis: A retrospective cohort study.

Blood, 2023 Oct 05

Birtamimab plus standard of care in light-chain amyloidosis: the phase 3 randomized placebo-controlled VITAL trial.

Related Topics in Cardiology